M. Gunaldi Et Al. , "Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment," PHARMACOLOGY , vol.94, pp.183-189, 2014
Gunaldi, M. Et Al. 2014. Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment. PHARMACOLOGY , vol.94 , 183-189.
Gunaldi, M., Erkisi, M., Afsar, C. U., Ercolak, V., PAYDAŞ, S., KARA, İ. O., ... ŞAHİN, B.(2014). Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment. PHARMACOLOGY , vol.94, 183-189.
Gunaldi, Meral Et Al. "Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment," PHARMACOLOGY , vol.94, 183-189, 2014
Gunaldi, Meral Et Al. "Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment." PHARMACOLOGY , vol.94, pp.183-189, 2014
Gunaldi, M. Et Al. (2014) . "Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment." PHARMACOLOGY , vol.94, pp.183-189.
@article{article, author={Meral Gunaldi Et Al. }, title={Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment}, journal={PHARMACOLOGY}, year=2014, pages={183-189} }